Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation
Post‐translational modifications (PTMs) have emerged as key modulators of protein phase separation and have been linked to protein aggregation in neurodegenerative disorders. The major aggregating protein in amyotrophic lateral sclerosis and frontotemporal dementia, the RNA‐binding protein TAR DNA‐b...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016352/ https://www.ncbi.nlm.nih.gov/pubmed/35112738 http://dx.doi.org/10.15252/embj.2021108443 |
_version_ | 1784688512890568704 |
---|---|
author | Gruijs da Silva, Lara A Simonetti, Francesca Hutten, Saskia Riemenschneider, Henrick Sternburg, Erin L Pietrek, Lisa M Gebel, Jakob Dötsch, Volker Edbauer, Dieter Hummer, Gerhard Stelzl, Lukas S Dormann, Dorothee |
author_facet | Gruijs da Silva, Lara A Simonetti, Francesca Hutten, Saskia Riemenschneider, Henrick Sternburg, Erin L Pietrek, Lisa M Gebel, Jakob Dötsch, Volker Edbauer, Dieter Hummer, Gerhard Stelzl, Lukas S Dormann, Dorothee |
author_sort | Gruijs da Silva, Lara A |
collection | PubMed |
description | Post‐translational modifications (PTMs) have emerged as key modulators of protein phase separation and have been linked to protein aggregation in neurodegenerative disorders. The major aggregating protein in amyotrophic lateral sclerosis and frontotemporal dementia, the RNA‐binding protein TAR DNA‐binding protein (TDP‐43), is hyperphosphorylated in disease on several C‐terminal serine residues, a process generally believed to promote TDP‐43 aggregation. Here, we however find that Casein kinase 1δ‐mediated TDP‐43 hyperphosphorylation or C‐terminal phosphomimetic mutations reduce TDP‐43 phase separation and aggregation, and instead render TDP‐43 condensates more liquid‐like and dynamic. Multi‐scale molecular dynamics simulations reveal reduced homotypic interactions of TDP‐43 low‐complexity domains through enhanced solvation of phosphomimetic residues. Cellular experiments show that phosphomimetic substitutions do not affect nuclear import or RNA regulatory functions of TDP‐43, but suppress accumulation of TDP‐43 in membrane‐less organelles and promote its solubility in neurons. We speculate that TDP‐43 hyperphosphorylation may be a protective cellular response to counteract TDP‐43 aggregation. |
format | Online Article Text |
id | pubmed-9016352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90163522022-04-28 Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation Gruijs da Silva, Lara A Simonetti, Francesca Hutten, Saskia Riemenschneider, Henrick Sternburg, Erin L Pietrek, Lisa M Gebel, Jakob Dötsch, Volker Edbauer, Dieter Hummer, Gerhard Stelzl, Lukas S Dormann, Dorothee EMBO J Articles Post‐translational modifications (PTMs) have emerged as key modulators of protein phase separation and have been linked to protein aggregation in neurodegenerative disorders. The major aggregating protein in amyotrophic lateral sclerosis and frontotemporal dementia, the RNA‐binding protein TAR DNA‐binding protein (TDP‐43), is hyperphosphorylated in disease on several C‐terminal serine residues, a process generally believed to promote TDP‐43 aggregation. Here, we however find that Casein kinase 1δ‐mediated TDP‐43 hyperphosphorylation or C‐terminal phosphomimetic mutations reduce TDP‐43 phase separation and aggregation, and instead render TDP‐43 condensates more liquid‐like and dynamic. Multi‐scale molecular dynamics simulations reveal reduced homotypic interactions of TDP‐43 low‐complexity domains through enhanced solvation of phosphomimetic residues. Cellular experiments show that phosphomimetic substitutions do not affect nuclear import or RNA regulatory functions of TDP‐43, but suppress accumulation of TDP‐43 in membrane‐less organelles and promote its solubility in neurons. We speculate that TDP‐43 hyperphosphorylation may be a protective cellular response to counteract TDP‐43 aggregation. John Wiley and Sons Inc. 2022-02-03 /pmc/articles/PMC9016352/ /pubmed/35112738 http://dx.doi.org/10.15252/embj.2021108443 Text en © 2022 The Authors. Published under the terms of the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Gruijs da Silva, Lara A Simonetti, Francesca Hutten, Saskia Riemenschneider, Henrick Sternburg, Erin L Pietrek, Lisa M Gebel, Jakob Dötsch, Volker Edbauer, Dieter Hummer, Gerhard Stelzl, Lukas S Dormann, Dorothee Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation |
title | Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation |
title_full | Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation |
title_fullStr | Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation |
title_full_unstemmed | Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation |
title_short | Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation |
title_sort | disease‐linked tdp‐43 hyperphosphorylation suppresses tdp‐43 condensation and aggregation |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016352/ https://www.ncbi.nlm.nih.gov/pubmed/35112738 http://dx.doi.org/10.15252/embj.2021108443 |
work_keys_str_mv | AT gruijsdasilvalaraa diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT simonettifrancesca diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT huttensaskia diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT riemenschneiderhenrick diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT sternburgerinl diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT pietreklisam diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT gebeljakob diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT dotschvolker diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT edbauerdieter diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT hummergerhard diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT stelzllukass diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation AT dormanndorothee diseaselinkedtdp43hyperphosphorylationsuppressestdp43condensationandaggregation |